Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 2002 Oct;11(5):299–306. doi: 10.1080/09629350210000015700

Effects of methotrexate upon inflammatory parameters induced by carrageenan in the mouse model of pleurisy.

Eduardo Monguilhott Dalmarco 1, Tânia Silvia Fröde 1, Yara Santos Medeiros 1
PMCID: PMC1781680  PMID: 12467522

Abstract

BACKGROUND: The model of pleurisy induced by carrageenan exhibits a biphasic response (4 and 48 h) and permits the quantification of exudate, cell migration and certain enzymes such as myeloperoxidase (MPO) and adenosine-deaminase (ADA) that are markers of activated leukocytes. AIMS: The present study evaluates whether there exists, in the pleurisy model, a significant inhibition of ADA and MPO enzymes, leukocyte kinetics and other markers of inflammation [nitric oxide (NO) levels, exudation] caused by methotrexate treatment by the intraperitoneal (i.p.) route. METHODS: The pleurisy was induced by carrageenan (1%) in mice, and the parameters were analyzed 4 and 48 h after. RESULTS: After the induction of inflammation (4 h), methotrexate (20 mg/kg, i.p., 24 h before pleurisy induction) inhibited the leukocyte infiltration (p < 0.05), NO levels and MPO activity (p < 0.01), but not ADA activity and fluid leakage (p > 0.05). Regarding the second phase of pleurisy (48 h), methotrexate (40 mg/kg, i.p., 0.5 h before pleurisy induction) inhibited the leukocyte infiltration (p < 0.05), fluid leakage, NO levels (p < 0.01), and ADA and MPO activity (p < 0.05). CONCLUSIONS: These findings support the evidence that the acute administration of methotrexate has an important systemic anti-inflammatory activity in the studied inflammatory model. This effect was due to a significant inhibition on both neutrophil and mononuclear cells, being less marked in relation to exudation 48 h after. In relation to the enzymes studied and to NO levels, the findings support the evidence that methotrexate inhibits both enzymes (MPO and ADA) from leukocytes at the site of injury, thus reflecting the activation of both neutrophils and lymphocytes, respectively. Furthermore, the inhibiting effect on NO in both phases of pleurisy induced by carrageenan (4 and 48 h) indicates that methotrexate acts on constitutive and/or inducible NO synthases by means of different cells of the pleural cavity.

Full Text

The Full Text of this article is available as a PDF (230.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chan G. L., Weinstein S. S., Vijayanagar R. R. Treatment of recalcitrant cardiac allograft rejection with methotrexate. Cardiac Transplant Team. Clin Transplant. 1995 Apr;9(2):106–114. [PubMed] [Google Scholar]
  2. Ciesielski C. J., Mei J., Piccinini L. A. Effects of cyclosporine A and methotrexate on CD18 expression in recipients of rat cardiac allografts. Transpl Immunol. 1998 Jun;6(2):122–133. doi: 10.1016/s0966-3274(98)80027-0. [DOI] [PubMed] [Google Scholar]
  3. Cronstein B. N., Montesinos M. C., Weissmann G. Sites of action for future therapy: an adenosine-dependent mechanism by which aspirin retains its antiinflammatory activity in cyclooxygenase-2 and NFkappaB knockout mice. Osteoarthritis Cartilage. 1999 Jul;7(4):361–363. doi: 10.1053/joca.1998.0236. [DOI] [PubMed] [Google Scholar]
  4. Cronstein B. N., Naime D., Ostad E. The antiinflammatory effects of methotrexate are mediated by adenosine. Adv Exp Med Biol. 1994;370:411–416. doi: 10.1007/978-1-4615-2584-4_89. [DOI] [PubMed] [Google Scholar]
  5. Cronstein B. N., Naime D., Ostad E. The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J Clin Invest. 1993 Dec;92(6):2675–2682. doi: 10.1172/JCI116884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cuzzocrea S., Mazzon E., Calabro G., Dugo L., De Sarro A., van De LOO F. A., Caputi A. P. Inducible nitric oxide synthase-knockout mice exhibit resistance to pleurisy and lung injury caused by carrageenan. Am J Respir Crit Care Med. 2000 Nov;162(5):1859–1866. doi: 10.1164/ajrccm.162.5.9912125. [DOI] [PubMed] [Google Scholar]
  7. De Gendt C. M., De Clerck L. S., Bridts C. H., Verbruggen A., Stevens W. J. Influence of antirheumatic drugs on nitric oxide and interleukin 8 production in human articular chondrocytes. J Rheumatol. 1998 Mar;25(3):536–538. [PubMed] [Google Scholar]
  8. Di Rosa M., Ialenti A., Ianaro A., Sautebin L. Interaction between nitric oxide and cyclooxygenase pathways. Prostaglandins Leukot Essent Fatty Acids. 1996 Apr;54(4):229–238. doi: 10.1016/s0952-3278(96)90053-8. [DOI] [PubMed] [Google Scholar]
  9. Elliott K. R., Miller P. J., Stevenson H. C., Leonard E. J. Synergistic action of adenosine and fMet-Leu-Phe in raising cAMP content of purified human monocytes. Biochem Biophys Res Commun. 1986 Aug 14;138(3):1376–1382. doi: 10.1016/s0006-291x(86)80435-1. [DOI] [PubMed] [Google Scholar]
  10. Fröde T. S., Medeiros Y. S. Myeloperoxidase and adenosine-deaminase levels in the pleural fluid leakage induced by carrageenan in the mouse model of pleurisy. Mediators Inflamm. 2001 Aug;10(4):223–227. doi: 10.1080/09629350123332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hayem G., Domarle O., Thuong-Guyot M., Pocidalo J. J., Meyer O. Effects of methotrexate on the oxidative metabolism of cultured rabbit articular chondrocytes. J Rheumatol. 2000 May;27(5):1117–1120. [PubMed] [Google Scholar]
  12. Leonard P. A., Clegg D. O., Carson C. C., Cannon G. W., Egger M. J., Ward J. R. Low dose pulse methotrexate in rheumatoid arthritis: an 8-year experience with hepatotoxicity. Clin Rheumatol. 1987 Dec;6(4):575–582. doi: 10.1007/BF02330596. [DOI] [PubMed] [Google Scholar]
  13. Mitchell M. S., Wade M. E., DeConti R. C., Bertino J. R., Calabresi P. Immunosuppressive effects of cytosine arabinoside and methotrexate in man. Ann Intern Med. 1969 Mar;70(3):535–547. doi: 10.7326/0003-4819-70-3-535. [DOI] [PubMed] [Google Scholar]
  14. Morabito L., Montesinos M. C., Schreibman D. M., Balter L., Thompson L. F., Resta R., Carlin G., Huie M. A., Cronstein B. N. Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides. J Clin Invest. 1998 Jan 15;101(2):295–300. doi: 10.1172/JCI1554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Omata T., Segawa Y., Inoue N., Tsuzuike N., Itokazu Y., Tamaki H. Methotrexate suppresses nitric oxide production ex vivo in macrophages from rats with adjuvant-induced arthritis. Res Exp Med (Berl) 1997;197(2):81–90. doi: 10.1007/s004330050057. [DOI] [PubMed] [Google Scholar]
  16. Rao T. S., Currie J. L., Shaffer A. F., Isakson P. C. Comparative evaluation of arachidonic acid (AA)- and tetradecanoylphorbol acetate (TPA)-induced dermal inflammation. Inflammation. 1993 Dec;17(6):723–741. doi: 10.1007/BF00920477. [DOI] [PubMed] [Google Scholar]
  17. Robbins R. A., Jinkins P. A., Bryan T. W., Prado S. C., Milligan S. A. Methotrexate inhibition of inducible nitric oxide synthase in murine lung epithelial cells in vitro. Am J Respir Cell Mol Biol. 1998 Jun;18(6):853–859. doi: 10.1165/ajrcmb.18.6.3070. [DOI] [PubMed] [Google Scholar]
  18. Saleh T. S., Calixto J. B., Medeiros Y. S. Anti-inflammatory effects of theophylline, cromolyn and salbutamol in a murine model of pleurisy. Br J Pharmacol. 1996 Jun;118(3):811–819. doi: 10.1111/j.1476-5381.1996.tb15472.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Saleh T. S., Calixto J. B., Medeiros Y. S. Effects of anti-inflammatory drugs upon nitrate and myeloperoxidase levels in the mouse pleurisy induced by carrageenan. Peptides. 1999;20(8):949–956. doi: 10.1016/s0196-9781(99)00086-8. [DOI] [PubMed] [Google Scholar]
  20. Sautebin L., Ialenti A., Ianaro A., Di Rosa M. Relationship between nitric oxide and prostaglandins in carrageenin pleurisy. Biochem Pharmacol. 1998 Apr 1;55(7):1113–1117. doi: 10.1016/s0006-2952(97)00530-3. [DOI] [PubMed] [Google Scholar]
  21. Vergne P., Liagre B., Bertin P., Cook-Moreau J., Treves R., Beneytout J. L., Rigaud M. Methotrexate and cyclooxygenase metabolism in cultured human rheumatoid synoviocytes. J Rheumatol. 1998 Mar;25(3):433–440. [PubMed] [Google Scholar]
  22. Weinblatt M. E., Coblyn J. S., Fox D. A., Fraser P. A., Holdsworth D. E., Glass D. N., Trentham D. E. Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med. 1985 Mar 28;312(13):818–822. doi: 10.1056/NEJM198503283121303. [DOI] [PubMed] [Google Scholar]
  23. Yanaguimoto H., Ishizuki S., Fujihira E. Anti-inflammatory effects of methotrexate on reversed passive Arthus reactions in rats. Res Commun Mol Pathol Pharmacol. 2000 May-Jun;107(5-6):377–386. [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES